Replimune board member Otello Stampacchia resigns to focus on Omega Funds duties

Replimune Group, Inc.

Director Otello Stampacchia resigned effective January 26, 2022; not due to any dispute with the company.
Stampacchia had served on the board since 2015, concurrent with Omega Funds co-leading Replimune's seed financing.
He steps down to focus on growing commitments at Omega Funds and its portfolio companies.
CEO Philip Astley-Sparke thanked Stampacchia for his contributions from concept to late-stage development.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Otello Stampacchia

Director

REPL · Replimune Group, Inc.

Effective: 2022-01-26
Filed: January 31, 2022, 6:59 PM ET

On January 26, 2022, Otello Stampacchia, Ph.D., a member of the Board of Directors (the “Board”) of Replimune Group, Inc. (the “Company”), notified the Board of his decision to resign as a director of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Otello Stampacchia resigned as Director at Replimune Group, Inc..

Action: resigned
Role: Director

Exact text from the filing

On January 26, 2022, Otello Stampacchia, Ph.D., a member of the Board of Directors (the “Board”) of Replimune Group, Inc. (the “Company”), notified the Board of his decision to resign as a director of the Company, effective immediately.

View on SEC.gov

Replimune Group, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-009561

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.